Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 465 results found. Search for [ Dr Reddy's Laboratories ]

Results 20 to 40 of 465
Aprajita Sharma
October 6, 2020
With the construction of MSCI India Domestic & World Healthcare 45 Index Fund for Edelweiss, the MSCI has forayed into the Indian market for the first time


Reuters
October 6, 2020
The Hyderabad-based pharmaceutical company had applied to the Drugs Controller General of India (DCGI) late last week, seeking permission to conduct phase-3 human clinical trials of the Russian vaccine


Anand Adhikari, Nevin John & Niti Kiran
New Delhi, September 30, 2020
India Inc. must brace up for large-scale ratings downgrade, defaults and assets sale


BusinessToday.In
September 28, 2020
Stocks to watch today on September 28: Reliance Industries, JSW Energy, Vodafone Idea, SBI, Dr Reddy among others are the top stocks to watch out for in Monday's trading session.


BusinessToday.In
September 23, 2020
The ESOP comprises of 6,774 equity shares of Rs 5 each under Dr. Reddy's Employees Stock Option Scheme and 7,510 equity shares of Rs 5 each under ADR Stock Option Scheme


BusinessToday.In
September 22, 2020
With the 800 mg of Favipiravir tablet, COVID-19 patients could undergo a more relaxed dosage, which will increase their compliance and experience


BusinessToday.In
New Delhi, September 18, 2020
Russian COVID-19 vaccine, 'Sputnik-V' which has been launched in Russia, may soon become the first official vaccine to be launched in India if clearances are granted. For this, GV Prasad-led Dr Reddy's Laboratories has signed a pact with Russia's sovereign wealth fund Russian Direct Investment Fund (RDIF) to manufacture around 10 crore vaccines in India. Both have been planning to roll out the vaccine in India as early as November. RDIF CEO Kirill Dmitriev spoke to India Today TV about the plans for the launch of vaccine in India. Watch this exclusive interview to know more.Also Read: Russian coronavirus vaccine: 1 in 7 volunteers report side-effects


BusinessToday.In
September 18, 2020
Russian COVID-19 vaccine: Volunteers would receive a second shot of the Russian COVID-19 vaccine within 21 days of the first shot. The adenovirus-based viral vector vaccine is yet to complete a large-scale clinical trial but has been approved by the Russian government


BusinessToday.In
September 18, 2020
Dr Reddy's Laboratories stock touched an all-time high of Rs 5,302 today rising 9.87% against previous close of Rs 4,826 on BSE


BusinessToday.In
September 18, 2020
Kirill Dmitriev, CEO of Russia's sovereign wealth fund Russian Direct Investment Fund, says India will play a vital role in fighting Covid-19 and that government's Make in India initiative has made pharma sector stronger


BusinessToday.In
September 18, 2020
India Stock Market Highlights Today: Sun Pharma, followed by Tech Mahindra, Tata Steel, TCS, Titan, PowerGrid, NTPC, Reliance Industries and Asian Paints were among the top gainers on Sensex today. On the other hand, HUL, Bajaj Auto, Maruti and Nestle India were among the laggards


BusinessToday.In
September 18, 2020
Stocks to watch today on September 18: Vedanta, Dr Reddy, Hindalco, EIH, TVS Motors among others are the top stocks to watch out for in Friday's trading session


BusinessToday.In
September 17, 2020
As part of the settlement, Celgene has agreed to provide Dr Reddy's with a licence to sell volume-limited amounts of generic lenalidomide capsules in the US after March 2022 subject to regulatory approval


BusinessToday.In
September 17, 2020
Dr Reddy's Laboratories stock which closed 4.24% higher in the previous session gained 4.21% or Rs 195 to close at Rs 4,826 on BSE today


BusinessToday.In
New Delhi, September 17, 2020
Premium bicycle maker Scott Sports India on Wednesday introduced a full suspension cross country bicycle Spark RC 900 at a whopping Rs 3.7 lakh; Software engineers, physicians, teachers, accountants, analysts, among others are the professionals  who saw the biggest loss of jobs among salaried employees due to coronavirus lockdown; Hyderabad-based Dr Reddy's Laboratories (Dr Reddy's) and Russia's sovereign wealth fund Russian Direct Investment Fund (RDIF) have joined hands to carry out clinical trials and distribution of 100 million doses of coronavirus vaccine Sputnik V in India. Watch this and more on News Blast.Also Read: 33% Delhiites exposed to coronavirus, have Covid antibodies, reveals latest sero survey


BusinessToday.In
New Delhi, September 17, 2020
COVID-19 vaccine from Russia! Dr Reddy's ties up with a Russian firm for 100 million dosesHyderabad-based Dr Reddy's Laboratories (Dr Reddy's) and Russia's sovereign wealth fund Russian Direct Investment Fund (RDIF) have joined hands to carry out clinical trials and distribution of 100 million doses of coronavirus vaccine Sputnik V in India. Sputnik V vaccine is undergoing final stage clinical trials in Russia. It is also being tested in several other countries. \"Deliveries could potentially...


BusinessToday.In
September 17, 2020
India Stock Market Highlights Today: ICICI Bank, HDFC Bank, PowerGrid, Bajaj Auto, Kotak Bank, Axis Bank and L&T were among the top losers today on the Sensex pack. On the other hand, HCL Tech, Tech Mahindra, Asian Paints, ONGC and Infosys were among the gainers


Joe C Mathew
September 16, 2020
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India, a joint statement issued by RDIF and Dr Reddy's says


BusinessToday.In
September 16, 2020
Dr Reddy's Lab share touched an intraday high of Rs 4651.95, a rise of 4.7% on BSE


Chitranjan Kumar
September 16, 2020
The Sputnik V vaccine, developed by the Gamaleya research institute in coordination with the Russian defence ministry, is the world's first registered vaccine against COVID-19 based on the human adenoviral vectors platform


PAGES 2 OF 24  12345